PODCAST · science
Life Sciences DNA Podcast
by Levine Media Group
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Episodes
-
Putting Business Value at the Center of AI in Biopharma
Artificial intelligence may be moving quickly, but life sciences companies cannot afford to treat it as a race for the latest shiny tool. In this episode of Life Sciences DNA, Brinda Banerjee, CIO of Stemline Therapeutics, sits down with Srivatsan Nagaraja to discuss how an oncology-focused...
-
Turning Data and AI Into Better Business Outcomes
Artificial intelligence is reshaping how biopharmaceutical companies discover, develop, commercialize, and support medicines. But realizing its potential requires far more than adopting the latest tools. Srivatsan Nagaraja speaks with Matt Lasmanis, chief digital officer at Jazz Pharmaceuticals,...
-
Measuring AI by Business Results in Life Sciences
Artificial intelligence is creating new opportunities to improve clinical development, but successful adoption requires more than choosing the latest model or launching isolated pilots. Krishna Cheriath, vice president and head of digital and AI for biopharma services at Thermo Fisher Scientific,...
-
Lessons from Insmed’s Journey to an AI First Biotech
Chris Colucci, vice president of information technology at Insmed, sits down with Nagaraja Srivatsan to discuss the company’s shift from AI experimentation to enterprise-scale adoption, using the patient as its North Star guiding decisions across the drug development value chain. He outlines the...
-
Human Accountability in an Agentic Pharma World
Vertex senior director Amrit Moola sits down with Srivatsan Nagaraja to discuss what it takes to operationalize AI in pharma and biotech from early experiments to large‑scale transformation. He describes how to pick high‑impact use cases, re‑architect processes around agents and real‑time data…
more -
Making AI Transformations that Stick
Vikram Nair, chief information officer of Amneal Pharmaceuticals, joins Srivatsan Nagaraja to break down what it really takes to turn AI from boardroom buzz into real business impact. From early missteps and skeptical stakeholders to building smarter metrics, Nair shares lessons from the front...
-
Finding ROI from AI in the Mundane
Dennis Salotti, executive director and head of clinical outsourcing and innovation at Jazz Pharmaceuticals, joins Srivatsan Nagaraja to talk about what AI really looks like in day-to-inside a drug company. He explains how large language models and agentic tools can streamline contracting,...
-
A Pragmatic Path to AI-Enabled Commercial Operations
Tris Pharma Chief Commercial Officer Manesh Naidu sits down with Nagaraja Srivatsan to discuss how the small but growing specialty pharma company is pursuing a deliberately incremental AI strategy, focusing on its biggest pain points rather than chasing grand, enterprise-wide transformations. He...
-
Reimagining Scientific Work in the Age of AI Agents
Shweta Maniar, global strategy and market leader for life sciences at Google Cloud, sits down with Nagaraja Srivatsan to unpack what it takes to turn AI pilots into durable, enterprise-wide impact. A former biotech executive who now helps biopharma leaders modernize their data and AI strategy,...
-
Orchestrating Scientists, Data, and AI to Discover New Drugs
Scotch McClure had a bold plan for Maxwell Biosciences to map and mine the roughly 3 percent of peptides circulating in human plasma. The company has harnessed AI to move from a massive and messy universe of human peptides to a small-molecule candidate that could offer a potential alternative to...
-
Scaling Practical AI Across Commercial Teams
Drew McCormick, head of data and analytics at Eversana, sits down with Nagaraja Srivatsan to trace the company’s AI journey from classic predictive modeling in its data and analytics business to an enterprise-wide strategy. He describes how Eversana is building on a strong data foundation to…
more -
Building an AI-Ready Biopharma Organization
Scott Cenci, chief information and data officer for Acadia Pharmaceuticals, sits down with Nagaraja Srivatsan to discuss how generative and agentic AI are reshaping biopharma throughout the enterprise from R&D and clinical development to the commercial field. He discusses how it is changing the...
-
Automating Biopharma Workflows with AI and Robotics
Karthik Raman, co-founder and CEO of Persist AI, sits down with the Nagaraja Srivatsan to discuss how robotics, AI, and cloud tech are supercharging drug formulation to address a bottleneck in pharma R&D. He explains how robots outperform humans in consistency and scale, igniting a flywheel of...
-
De-Risking Discovery and Improving the Success Rates of Drug Development with AI
Gabi Tarcic, vice president of product for Evogene, sits down with Srivatsan Nagaraja about applying AI to small molecule drug discovery, the cultural and operational changes required for researchers to adopt these tools, and how AI-driven platforms can improve the efficiency of pharma R&D.
-
Agents of Change: Creating Regulatory Documents with AI
Anita Modi, CEO and founder of Peer AI, joins Srivatsan Nagaraja to discuss the transformative impact of agentic AI on document creation for pharmaceutical companies. She discusses the cultural challenges of integrating AI into a traditionally cautious industry, the need for change management…
more -
Redefining Biomarkers for Immune-Mediated Disease with AI
Ronel Veksler, co-founder and CEO of PromiseBio, sits down with Amar Drawid to discuss the company’s AI-enabled proteomics platform, and how post-translational modifications of proteins represent a new frontier for precision medicine in autoimmune diseases; and how AI is enabling deep profiling…
more -
Driving Insights from Real World Oncology Data with AI
Aaron Cohen, Head of Research Oncology, Clinical Data for Flatiron Health, sits down with Amar Drawid to discuss Flatiron’s use of large language models to extract and analyze unstructured data from electronic health records. Cohen discusses how AI‑extracted data can replicate human‑curated...
-
Improving Drug Development with Real-World Data
Manfred Stapff, founder and principal of Candid Advisory, sits down with Amar Drawid to discuss the potential of real-world data to accelerate drug development and improve regulatory strategies. He discusses why real-world data can provide insights may miss, shed light on treatment effects once...
-
Navigating the AI Landscape in Clinical Development
Stephen Pyke, chief clinical data and digital officer at Parexel, sits down with Srivatsan Nagaraja to discuss the adoption of AI technologies in clinical development. He highlights the importance of workflow integration, the challenges of change management, and how to prepare organizations for…
more -
Transforming Cancer Diagnostics and Care with AI
Mohan Uttarwar, CEO 1Cell.Ai, sits down with Amar Drawid to discuss how his company is transforming cancer diagnostics and care by combining cutting-edge molecular science with advanced AI. He talks about how the company’s single-cell multi-omics platform provides real-time, precision insights,...
-
Moving Beyond the Hype of AI in Biopharma
Amar Drawid, vice president and global head of data analytics, insights, and AI for BioNTech, sits down with Nagaraja Srivatsan to discuss the evolution, adoption, and challenges of AI in the biopharma sector. He discusses the real-world implementation challenges of generative AI, the iterative...
-
Why AI’s Most Promising Near-Term Value Is in Clinical Operations
Dimitris Agrafiotis, director of digital analytics and AI at Arsenal Capital Partners sits down with Nagaraja Srivatsan to discuss the current state of AI in clinical trials, the potential for AI to streamline operations, and the importance of user experience and change management in driving...
-
Teaching the Biopharma Workforce to Coexist with AI
Sunil Talathi, senior director and head of data insights, data sciences, and analytics for BeOne Medicines; sits down with Nagaraja Srivatsan to discuss his experience implementing AI in a biopharmaceutical company. He discusses cost considerations, prompt engineering, and the need for...
-
Making Clinical Trials More Predictable with AI
Craig Lipset, advisor and founder of Clinical Innovation Partners, sits down with Nagaraja Srivatsan to discuss how AI can bring greater predictability to clinical trials, how organizations can adopt the technology effectively, and the importance of having a culture of experimentation.
-
Finding Healthcare Providers from Clinical Trials to War Zones
Ariel Katz, co-founder and CEO of H1, sits down with Amar Drawid to discuss how his company’s AI platform allows pharmaceutical companies to identify the right healthcare providers for their clinical trials, medical affairs, and commercial activities. He discusses the company’s unique datasets…
more -
Driving Efficiency in Drug Development with AI
Venky Iyer, director of data strategy and automation at Pfizer, sits down with Nagaraja Srivatsan to discuss the transformative role of AI and machine learning in the pharmaceutical industry. They discuss Iyer’s journey in implementing AI solutions to enhance operational efficiency at Pfizer.…
more -
Improving Clinical Trial Designs with AI
Scott Chetham, co-founder and CEO of Faro Health, sits down with Amar Drawid to discuss how AI transforms clinical trial design and drug development. He talks about how AI can enhance patient selection, feasibility assessments, and protocol writing to accelerate drug development cost-effectively.
-
Improving the Efficiency of the Pharma Workforce with AI
Kannan Natarajan, senior vice president at Pfizer, discusses the potential of generative AI to streamline pharmaceutical documentation processes and improve efficiency, what he’s learned about implementing AI solutions, and the cultural challenges of adopting new technologies.
-
Navigating AI Implementation in Pharma
Vinod Das, Pharma R&D, Drug Innovation & AI Scouting for Bayer; sits down with Nagaraja Srivatsan to discuss the integration of generative AI in drug discovery and clinical development. He discusses the journey of AI adoption, the importance of prompt engineering, and the complexities of...
-
Transforming Cancer Care in India with AI
Vijayalakshmi Ramshankar, professor and head of the Department of Cancer Biology and Molecular Diagnostics at Cancer Institute (WIA) sits down with Nagaraja Srivatsan to discuss the cancer research landscape in India, the work she is doing to leverage AI to improve diagnosis and outcomes, and the...
-
Navigating the Challenges of Integrating AI in Clinical Development
Manoranjan Das, director of global drug development IT for Bristol Myers Squibb, sits down with Nagaraja Srivatsan to discuss his work to implement AI in clinical development, the importance of change management, and the lessons learned from various AI projects he’s led.
-
Leveraging AI in Clinical Development
Aman Thukral, director of Clinical Systems And Digital Operations at AbbVie, sits down with Nagaraja Srivatsan to discuss the evolving landscape of clinical trials with the integration of AI, why change management is essential for successful implementation, and the need for a long-term investment...
-
Integrating AI into Precision Medicine
Tobias Guennel, senior vice president of product innovation and co-founder of QuartzBio, joins Nagaraja Srivatsan to discuss his insights on leveraging AI and advanced analytics to improve clinical trial efficiency, the integration of AI in precision medicine, and the use of AI agents to automate...
-
Transforming Clinical Development with AI
Bhaskar Sambasivan, CEO of Saama, sits down with Nagaraja Srivatsan to discuss the transformative role of AI in clinical development, why AI adoption will be a CEO mandate, and why the future of AI in drug development will be about autonomous decision-making.
-
Generating Proteins Nature Never Imagined
Mike Nally, CEO of Generate Biomedicines, sits down with Amar Drawid to discuss the innovative use of generative AI in drug discovery, how the company’s platform integrates machine learning with biological engineering to create new therapeutic proteins, and the potential of generative AI to…
more -
Why Data Strategy Must Be Tied to Business Outcomes
Kannan Raman of Amazon Web Service sits down with Amar Drawid to discuss the role of AI in transforming life sciences and the importance of data strategy being tied to business outcomes. They explore the challenges of data strategy, the importance of cultural shifts within organizations, and the...
-
Biopharma Companies Wrestle with an Outsized Demand for AI Talent
The increasing demand for AI talent in the life sciences industry is presenting a challenge for biopharma HR departments. Companies must compete for skilled workers not only against their competitors but also against tech firms that often offer more attractive compensation packages. Steve Swan…
more -
Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t
Monoclonal antibodies have been an important addition to the biomedical arsenal, but these therapies have limited ability to target a group of cell surface receptors known as GPCRs. Aikium is developing a new class of therapies known as SeqR proteins that offer an alternative to antibody-based...
-
Unlocking Market Access with AI
Rick Lloyd, founder and senior healthcare advisor of Range Health Advisors, sits down with Amar Drawid to discuss the intricacies of market access in the pharmaceutical industry, the importance of data analytics and AI in navigating the complexities of pricing and reimbursement, and how…
more -
Ensuring Successful Implementation of AI
Anastasia Christianson, AI and data analytics senior consultant and strategic advisor to life sciences and healthcare companies, sits down with Amar Drawid to discuss the integration of AI in the pharmaceutical industry, the importance of organizational models, and why its important for teams...
-
Tackling the New Bottleneck of Drug Discovery
Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enables drug developers to design complex experiments, run them, and capture and analyze the data all in an automated way.
-
Swimming in the Deep End of AI
Brendan Frey, founder and chief innovation officer of Deep Genomics, sits down with Amar Drawid to discuss how the company is using deep learning to leverage massive RNA biology datasets to drive the development of new therapies.
-
Using AI to Make Biology Easier to Engineer
Ankit Gupta, the head of AI and Senior Director of Machine Learning Research for Ginkgo Bioworks sits down with Amar Drawid to discuss bioengineering beyond healthcare, how the company is using generative AI and large language models to accelerate bioengineering, it expects this to revolutionize...
-
How AI ls Reshaping the Future of Healthcare
Subodha Kumar, professor of statistics, operations, and data science and the founding director of the Center for Business Analytics and Disruptive Technologies at Temple University’s Fox School of Business, sits down with Amar Drawid to discuss how AI will improve operational efficiency in...
-
A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI
Mati Gill, CEO of AION Labs, sits down with Amar Drawid to discuss how the AI venture studio works with its Big Pharma partners to define the biggest drug development hurdles the industry faces; and how it holds challenges to attract academics, entrepreneurs, and life sciences professionals with...
-
Decoding the Immune System to Optimize Immunotherapies
Noam Solomon, co-founder and CEO of Immunai, sits down with Amar Drawid to discuss how the company is using machine learning to take a multi-omics approach to understanding the complexities of the immune system, how it is constructing an atlas of immune cells, and how it is leveraging this to...
-
Bringing Precision Medicine to Mental Health with AI
Behavioral health is one area of medicine that has lagged in the move towards precision medicine, in part because of a lack of high-quality evidence to drive decision-making. Holmusk is working to change that by using AI and real-world data to transform mental health care. Eze Abosi, chief growth...
-
The Power and Peril of Generative AI in Biopharma and Healthcare
Healthtech and AI Executive Advisor Christian Hein sits down with Amar Drawid to discuss the use of generative AI in the life sciences, its transformational potential, and the current challenges that need to be addressed.
-
Unlocking the Complexity of Disease with Transomics and AI
Samantha Dale Strasser, co-founder and chief scientific officer of Pepper Bio, sits down with Amar Drawid to discuss how her company is leveraging AI to get a deeper understanding of disease biology through the use of transomics. We spoke to Strasser about the challenges studying complex…
more -
Why Biopharma Companies Should Recognize Data Analytics and AI as Strategic Advantages
Nagaraja Srivatsan, founder of the consulting firm Vidya Seva, sits down with Amar Drawid to discuss the application of data analytics and AI to healthcare and the life sciences, how it has evolved, and why it will be a competitive differentiator for companies that successfully capitalize the...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
HOSTED BY
Levine Media Group
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Life Sciences DNA Podcast have?
Life Sciences DNA Podcast currently has 52 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Life Sciences DNA Podcast about?
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from...
How often does Life Sciences DNA Podcast release new episodes?
Life Sciences DNA Podcast has 52 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Life Sciences DNA Podcast?
You can listen to Life Sciences DNA Podcast on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Life Sciences DNA Podcast?
Life Sciences DNA Podcast is created and hosted by Levine Media Group.
URL copied to clipboard!